Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension.
AI video platform for large-scale video automation
MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.
LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.
ClearScore is a fintech company that provides free credit scores, credit reports, and financial product recommendations to consumers.
Bambusa Therapeutics operates as biotechnology company.
Dorsia is a members-only platform that offers reservations at in-demand restaurants in major cities
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.
Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.
Amount is a digital technology company that accelerates digital transformation for financial institutions.
Abata Therapeutics develops regulatory T cell (Treg) therapies for treating autoimmune diseases including progressive multiple sclerosis.
KNIME provides a platform for end-to-end data science and analytics.
Averna Therapeutics develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.
Viseon is a privately held medical device company committed to developing proprietary technology.
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
Pi Health is a provider of platforms to assist oncology-related clinical trials with identifying sites and helping sponsors manage sites
Mission Lane is a consumer finance company dedicated to helping everyone have access to fair and clear credit.
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
Adevinta is a digital marketplace that provides online classifieds services.
Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.
Invus has invested in 117 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Invus's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 30 different industry categories.
Among tracked funding rounds, Hemab received $157.0M in a Series C round. Invus's total known invested capital is $9.5B.
Invus's average investment size is $93.6M across its portfolio of 117 companies.
Recent Invus portfolio additions include Ablative Solutions, Aive, MaaT Pharma, Hemab, Rani Therapeutics. These companies were founded in 2020 or later.